TVM Life Sciences Management

TVM Capital Life Science is a prominent international venture capital firm focused on the life sciences sector, with a history spanning over 35 years. The firm invests in biopharmaceutical, diagnostic, and medical technology companies across North America and Europe, managing assets through various specialized funds. A hallmark of their approach is the "Project-Focused Company" (PFC) model, which involves investing in single-asset entities to advance early-stage drug candidates toward clinical proof-of-concept. TVM maintains a strategic relationship with Eli Lilly and Company, facilitating a streamlined path for drug development and potential exits for high-potential therapeutic assets.